|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1201 Maryland Avenue SW |
Address2 | Suite 900 |
| City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 6245-12
|
||||||||
|
6. House ID# 325050000
|
||||||||
| TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Brent DelMonte, Vice President for Federal Government Relations |
Date | 07/20/2012 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
EPA Regulations on Agricultural Biotechnology
Departments of the Interior, Environment, and Related Agencies Appropriations Act for FY 2013
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
Coexistence of Production Systems
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
Biotechnology Stewardship
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Genetically Engineered Animals
Labeling
FDA Approval
S. 1717: Prevention of Escapement of Genetically Altered Salmon in the United States Act of 2012
S.R.2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
Amendment to Restrict FDA Approval of GE Salmon
S. 3187: Food and Drug Administration Safety and Innovation Act of 2012
Amendment to Restrict FDA Approval of GE Salmon
Export Registrations for Products with Expired Patents
Labeling of Genetically Engineered Crops
S.R.2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Amendment to Require Labeling of Biotech Food
TransPacific Partnership
Sanitary and Phytosanitary Issues
Adventitious Presence (Low Level Presence)
U.S. Low Level Presence Policy
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
Funding for USDA (Office of General Counsel, Biotechnology Regulatory Services, National Institute of Food and Agriculture, APHIS, Trade Activities (Office of the Secretary & Food Safety Inspection Service), National Resources Conservation Service, Agriculture Research Service, Biofuels, Foreign Agriculture Service)
S.R.2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
Foreign Agricultural Biotechnology Laws and Regulations
Low-Level Presence Foreign Government Policies
EU Biotechnology Bilateral Discussions
China Biotechnology Regulations
European Union Low Level Presence Policy
International Biotechnology Agreement
Asynchrony of International Approvals
Agricultural Biotechnology Regulatory Reform and Modernization
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
Benefits of Ag-Biotech Research and Innovation
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
Patent Exhaustion
Ag-biotech Products
Potential Regulation of New Genetic Modification Technologies
Biomass Crop Assistance Program
Funding
Renewal
S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), U.S. Trade Representative (USTR), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), White House Office, Patent & Trademark Office (PTO)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Tracey |
LaTurner |
|
|
|
Dana |
O'Brien |
|
|
|
Matthew |
O'Mara |
|
|
|
Brent |
Del Monte |
|
|
|
Derrick |
White |
|
|
|
Anna. |
Weinstein |
|
|
|
Hans |
Sauer |
|
|
|
Tom |
DiLenge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Genetically Engineered Animals
Labeling
FDA Approval
S. 1717: Prevention of Escapement of Genetically Altered Salmon in the United States Act of 2012
S.R.2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
Amendment to Restrict FDA Approval of GE Salmon
S. 3187: Food and Drug Administration Safety and Innovation Act of 2012
Amendment to Restrict FDA Approval of GE Salmon
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), U.S. Trade Representative (USTR), Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Dana |
O'Brien |
|
|
|
Derrick |
White |
|
|
|
Brent |
Del Monte |
|
|
|
Anna |
Weinstein |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for USDA (Office of General Counsel, Biotechnology Regulatory Services, National Institute of Food and Agriculture, APHIS, Trade Activities (Office of the Secretary & Food Safety Inspection Service), National Resources Conservation Service, Agriculture Research Service, Biofuels, Foreign Agriculture Service)
S.R.2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013
Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure)
S.R.2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
Funding for Bio-based Products
S.R. 2465/H.R. 5325: Energy and Water and Related Agencies Appropriations Act for FY 2013
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
Funding for Biofuels
S.R. 2465/H.R. 5325: Energy and Water and Related Agencies Appropriations Act for FY 2013
Funding for Biorefineries
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
S.R. 2465/H.R. 5325: Energy and Water and Related Agencies Appropriations Act for FY 2013
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
Funding for Centers for Disease Control and Prevention Vaccine Programs
S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013
Funding for National Institutes of Health
Cures Acceleration Network
National Center for Advancing Translational Science (NCATS)
S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013
Funding for Renewable Chemicals
S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
Funding for Biomass Crop Assistance Program
S.R.2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Natl Institutes of Health (NIH),
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sarah |
Thornton Caswell |
|
|
|
Matt |
Carr |
|
|
|
Cathleen |
Enright |
|
|
|
Andrew |
Emmett |
|
|
|
Cartier |
Esham |
|
|
|
David |
Edwards |
|
|
|
Dana |
O'Brien |
|
|
|
Sara |
Radcliffe |
|
|
|
. |
. |
|
|
|
Brent |
DelMonte |
|
|
|
Kelly |
Cappio |
|
|
|
Phyllis |
Arthur |
|
|
|
Tracey |
LaTurner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
Climate Change Benefits of Biofuels
Department of Defense Applications of Advanced Biofuels
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Navy - Dept of,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dana |
O'Brien |
|
|
|
Matt |
Carr |
|
|
|
Sarah |
Thornton Caswell |
|
|
|
Brent |
Del Monte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Patent Reform
Implementation of H.R. 1249: The America Invents Act of 2011
Technical Corrections of H.R. 1249: The America Invents Act of 2011
World Trade Organization Special 301 Submissions
India Issues
Genetic Resource Patent Disclosure Requirement
World Intellectual Property Organization
DNA Patenting and Licensing
Confirmatory Genetic Diagnostic Testing
Subject Matter Eligibility
Intellectual Property International Enforcement
International Trade Commission Reform
Rep. Devin Nunes Discussion Draft
TransPacific Partnership
Data and Intellectual Property Protections for Pharmaceuticals
Patent Exhaustion
Ag-biotech Products
Process Patents
Subject Matter Eligibility
PTO Guidance
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Patent & Trademark Office (PTO), State - Dept of (DOS), U.S. Trade Representative (USTR), Justice - Dept of (DOJ), Commerce - Dept of (DOC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lila |
Feisee |
|
|
|
Hans |
Sauer |
|
|
|
Charles |
Fritts |
|
|
|
Brent |
Del Monte |
|
|
|
Tom |
DiLenge |
|
|
|
Joseph |
Damond |
|
|
|
Roy |
Zwahlen |
|
|
|
Anna |
Weinstein |
|
|
|
Jeanne |
Haggerty |
|
|
|
Matthew |
Schumaker |
|
|
|
Dana |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
Coexistence of Production Systems
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
Genetically Engineered Animals
Labeling
FDA Approval
S. 1717: Prevention of Escapement of Genetically Altered Salmon in the United States Act of 2012
S.R.2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013 Amendment to Restrict FDA Approval of GE Salmon
S. 3187: Food and Drug Administration Safety and Innovation Act of 2012
Amendment to Restrict FDA Approval of GE Salmon
Labeling of Genetically Engineered Crops
S.R.2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Amendment to Require Labeling of Biotech Food
Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization
Critical Path Initiative
E-Pedigree and Anti-Counterfeiting
Regulatory Reforms for Innovative Products
Supply Chain Integrity
Conflicts of Interest
FDA Mission
Drug Shortages
Expedited Approval Pathways
Access to External Experts
FDA Globalization Act (Discussion Draft)
Senate HELP Committee Discussion Draft
House Energy and Commerce Committee Discussion Draft
H.R.4132: Faster Access to Specialized Treatments (FAST) Act
S. 3187:The Food and Drug Administration Safety and Innovation Act
S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011
H.R.2182: Generating Antibiotic Incentives Now Act of 2011
H.R.3214: Food and Drug Administration Mission Reform Act of 2011
H.R.1483: Drug Safety Enhancement Act of 2011
Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure)
S.R.2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
Reporting of Physician Payments
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), White House Office, U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Andrew |
Emmett |
|
|
|
Anna |
Weinstein |
|
|
|
Sara |
Radcliffe |
|
|
|
Sandra |
Dennis |
|
|
|
Derrick |
White |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Matthew |
O'Mara |
|
|
|
Matthew |
Schumaker |
|
|
|
Brent |
Del Monte |
|
|
|
Cartier |
Esham |
|
|
|
Tom |
DiLenge |
|
|
|
Alyson |
Pusey |
|
|
|
Jeanne |
Haggerty |
|
|
|
Kelly |
Cappio |
|
|
|
Phyllis |
Arthur |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
Renewable Fuels Standard
Implementation of Energy Independence and Security Act of 2007
Regulatory Oversight
S.R. 2465/H.R. 5325: Energy and Water and Related Agencies Appropriations Act for FY 2013
Biofuels
Funding
Department of Defense Applications of Advanced Biofuels
Biofuels Production Tax Credit Extension
Biofuels Production Tax Credit Modification for Algae-based Biofuels
Next Generation Incentives
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
S.R. 2465/H.R. 5325: Energy and Water and Related Agencies Appropriations Act for FY 2013
H.R. 5955: Rural Energy Investment Act of 2012
S.2155: To Amend the Farm Security and Rural Investment Act of 2002 to Promote Bio-based Manufacturing
S.2270: Rural Energy Investment Act of 2012
Biorefineries
Funding
Renewal of Biorefinery Assistance Program
Next Generation Incentives
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
S.R. 2465/H.R. 5325: Energy and Water and Related Agencies Appropriations Act for FY 2013
H.R. 5955: Rural Energy Investment Act of 2012
S.2155: To Amend the Farm Security and Rural Investment Act of 2002 to Promote Bio-based Manufacturing
S.2270: Rural Energy Investment Act of 2012
Bio-based Products
Funding
Tax Credit
Expansion of DOE and USDA Loan Guarantee Programs
USDA Bio-Preferred Program
Next Generation Incentives
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
S.R. 2465/H.R. 5325: Energy and Water and Related Agencies Appropriations Act for FY 2013
H.R. 5955: Rural Energy Investment Act of 2012
S.2155: To Amend the Farm Security and Rural Investment Act of 2002 to Promote Bio-based Manufacturing
S.2270: Rural Energy Investment Act of 2012
Renewable Chemicals
Funding
New Production Tax Credit/Revisions to Existing Tax Credits
DOE Loan Guarantees
Implementation of the Farm Security and Rural Investment Act of 2002
S.R. 2465/H.R. 5325: Energy and Water and Related Agencies Appropriations Act for FY 2013
S. 1764: Make It in America Tax Credit Act of 2011
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
H.R. 4953: Qualifying Renewable Chemical Production Tax Credit Act of 2012
H.R. 5955: Rural Energy Investment Act of 2012
S.2155: To Amend the Farm Security and Rural Investment Act of 2002 to Promote Bio-based Manufacturing
S.2270: Rural Energy Investment Act of 2012
Biomass Crop Assistance Program
Funding
Renewal
S.R.2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Energy - Dept of, Navy - Dept of, U.S. SENATE, Environmental Protection Agency (EPA), Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Charles |
Fritts |
|
|
|
Rina |
Singh |
|
|
|
Sarah |
Thornton Caswell |
|
|
|
Brent |
Del Monte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Genetically Engineered Animals
Labeling
FDA Approval
S. 1717: Prevention of Escapement of Genetically Altered Salmon in the United States Act of 2012
S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
Amendment to Restrict FDA Approval of GE Salmon
S. 3187: Food and Drug Administration Safety and Innovation Act of 2012
Amendment to Restrict FDA Approval of GE Salmon
Labeling of Genetically Engineered Crops
S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Amendment to Require Labeling of Biotech Food
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Brent |
Del Monte |
|
|
|
Derrick |
White |
|
|
|
Anna |
Weinstein |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FUE
16. Specific lobbying issues
Renewable Fuels Standard
Implementation of Energy Independence and Security Act of 2007
Regulatory Oversight
S.R. 2465/H.R. 5325: Energy and Water and Related Agencies Appropriations Act for FY 2013
Biofuels
Funding
Department of Defense Applications of Advanced Biofuels
Biofuels Production Tax Credit Extension
Biofuels Production Tax Credit Modification for Algae-based Biofuels
Next Generation Incentives
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
S.R. 2465/H.R. 5325: Energy and Water and Related Agencies Appropriations Act for FY 2013
H.R. 5955: Rural Energy Investment Act of 2012
S.2155: To Amend the Farm Security and Rural Investment Act of 2002 to Promote Bio-based Manufacturing
S.2270: Rural Energy Investment Act of 2012
Biorefineries
Funding
Renewal of Biorefinery Assistance Program
Next Generation Incentives
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
S.R. 2465/H.R. 5325: Energy and Water and Related Agencies Appropriations Act for FY 2013
H.R. 5955: Rural Energy Investment Act of 2012
S.2155: To Amend the Farm Security and Rural Investment Act of 2002 to Promote Bio-based Manufacturing
S.2270: Rural Energy Investment Act of 2012
Bio-based Products
Funding
Tax Credit
Expansion of DOE and USDA Loan Guarantee Programs
USDA Bio-Preferred Program
Next Generation Incentives
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
S.R. 2465/H.R. 5325: Energy and Water and Related Agencies Appropriations Act for FY 2013
H.R. 5955: Rural Energy Investment Act of 2012
S.2155: To Amend the Farm Security and Rural Investment Act of 2002 to Promote Bio-based Manufacturing
S.2270: Rural Energy Investment Act of 2012
Renewable Chemicals
Funding
New Production Tax Credit/Revisions to Existing Tax Credits
DOE Loan Guarantees
Implementation of the Farm Security and Rural Investment Act of 2002
S.R. 2465/H.R. 5325: Energy and Water and Related Agencies Appropriations Act for FY 2013
S. 1764: Make It in America Tax Credit Act of 2011
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
H.R. 4953: Qualifying Renewable Chemical Production Tax Credit Act of 2012
H.R. 5955: Rural Energy Investment Act of 2012
S.2155: To Amend the Farm Security and Rural Investment Act of 2002 to Promote Bio-based Manufacturing
S.2270: Rural Energy Investment Act of 2012
Biomass Crop Assistance Program
Funding
Renewal
S.R.2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Federal Agriculture Reform and Risk Management Act of 2012 (House Farm Bill Discussion Draft)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Energy - Dept of, Agriculture - Dept of (USDA), Navy - Dept of, Environmental Protection Agency (EPA),
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Charles |
Fritts |
|
|
|
Rina |
Singh |
|
|
|
Sarah |
Thornton Caswell |
|
|
|
Brent |
Del Monte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Biosimilars
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Reimbursement Issues
Comparative Effectiveness Research Initiatives
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Funding for National Institutes of Health
Cures Acceleration Network
National Center for Advancing Translation Science (NCATS)
S. 3295: Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013
Funding for Centers for Disease Control and Prevention Vaccine Programs
S. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013
Reporting of Physician Payments
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Vaccine Access/Financing
Tax for Seasonal Influenza Funding
Adult Immunization Policies
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
340B Drug Pricing Program
HRSA Implementation of Program Changes
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Rare Pediatric & Tropical Disease Drug Development
Drug Safety and Review/Prescription Drug User Fee Act (PDUFA) Reauthorization
Critical Path Initiative
E-Pedigree and Anti-Counterfeiting
Regulatory Reforms for Innovative Products
Supply Chain Integrity
Conflicts of Interest
FDA Mission
Drug Shortages
Expedited Approval Pathways
Access to External Experts
FDA Globalization Act (Discussion Draft)
Senate HELP Committee Discussion Draft
House Energy and Commerce Committee Discussion Draft
H.R.4132: Faster Access to Specialized Treatments (FAST) Act
S. 3187:The Food and Drug Administration Safety and Innovation Act
S. 2113: Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act of 2011
H.R.2182: Generating Antibiotic Incentives Now Act of 2011
H.R.3214: Food and Drug Administration Mission Reform Act of 2011
H.R.1483: Drug Safety Enhancement Act of 2011
Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure)
S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
Independent Payment Advisory Board
H.R. 5: Protecting Access to Healthcare Act of 2011
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013
Biodefense Research, Development and Procurement (Non-Funding Issues)
S. 1855: Pandemic and All Hazards Preparedness Act (PAHPA) Reauthorization of 2011
Reimbursement for Innovative Products
Medicare Part B Physician-Administered Products
Medicare Part D Prescription Drug Program
TransPacific Partnership
Data and Intellectual Property Protection for Pharmaceuticals
Regulatory Transparency
Therapeutic Discovery Project Tax Credit
Extension
S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care
Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shelly |
Mui-Lipnik |
|
|
|
Roy |
Zwahlen |
|
|
|
Sandra |
Dennis |
|
|
|
Andrew |
Emmett |
|
|
|
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Sara |
Radcliffe |
|
|
|
Phyllis |
Arthur |
|
|
|
Anna |
Weinstein |
|
|
|
Derrick |
White |
|
|
|
Cartier |
Esham |
|
|
|
Lila |
Feisee |
|
|
|
Tom |
DiLenge |
|
|
|
Tracey |
LaTurner |
|
|
|
Laurel |
Todd |
|
|
|
Brent |
Del Monte |
|
|
|
Alan |
Eisenberg |
|
|
|
Charles |
Fritts |
|
|
|
Alyson |
Pusey |
|
|
|
Kelly |
Cappio |
|
|
|
Joseph |
Damond |
|
|
|
Charles |
Crain |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013
Biodefense Research, Development and Procurement (Non-Funding Issues)
S. 1855: Pandemic and All Hazards Preparedness Act Reauthorization of 2011
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alyson |
Pusey |
|
|
|
Anna |
Weinstein |
|
|
|
Phyllis |
Arthur |
|
|
|
Matthew |
Schumaker |
|
|
|
Tracey |
LaTurner |
|
|
|
Jeanne |
Haggerty |
|
|
|
Brent |
Del Monte |
|
|
|
Sara |
Radcliffe |
|
|
|
Kelly |
Cappio |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Comparative Effectiveness Research Initiatives
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Rare Pediatric & Tropical Disease Drug Development
Funding for National Institutes of Health
Cures Acceleration Network
National Center for Advancing Translation Science (NCATS)
S.R. 3295: Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S.R.3295: Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act for FY 2013
Biodefense Research, Development and Procurement (Non-Funding Issues)
S. 1855: Pandemic and All Hazards Preparedness Act Reauthorization of 2011
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Tracey |
LaTurner |
|
|
|
Anna |
Weinstein |
|
|
|
Laurel |
Todd |
|
|
|
Phyllis |
Arthur |
|
|
|
Cartier |
Esham |
|
|
|
Kelly |
Cappio |
|
|
|
Brent |
Del Monte |
|
|
|
Sara |
Radcliffe |
|
|
|
Alyson |
Pusey |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Reimbursement for Innovative Products
Medicare Part B Physician-Administered Products
Medicare Part D Prescription Drug Program
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alyson |
Pusey |
|
|
|
Laurel |
Todd |
|
|
|
Sara |
Radcliffe |
|
|
|
Brent |
Del Monte |
|
|
|
Jeanne |
Haggerty |
|
|
|
Matthew |
Schumaker |
|
|
|
Derrick |
White |
|
|
|
Anna |
Weinstein |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
Research & Development Tax Credit Extension
Small Business Innovation Research (SBIR) Program
Rulemaking
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Small Business Adminstration (SBA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cartier |
Esham |
|
|
|
Charles |
Fritts |
|
|
|
Brent |
Del Monte |
|
|
|
Alan |
Eisenberg |
|
|
|
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SMB
16. Specific lobbying issues
Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions
Small Business Innovation Research (SBIR) Program
Rulemaking
Therapeutic Discovery Project Tax Credit
Extension
S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable
Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program
Capital Formation Investment Incentives
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Small Business Adminstration (SBA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cartier |
Esham |
|
|
|
Charles |
Fritts |
|
|
|
Alan |
Eisenberg |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Charles |
Crain |
|
|
|
Brent |
Del Monte |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Vaccine Access/Financing
Tax for Seasonal Influenza Funding
Bio-based Products
Tax Credit
Biofuels
Biofuels Production Tax Credit Extension
Biofuels Production Tax Credit Modification for Algae-based Biofuels
Renewable Chemicals
New Production Tax Credit/Revisions to Existing Tax Credits
S. 1764: Make It in America Tax Credit Act of 2011
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
H.R. 4953: Qualifying Renewable Chemical Production Tax Credit Act of 2012
Therapeutic Discovery Project Tax Credit
Extension
S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable
Care Act to Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program
Capital Formation Investment Incentives
Research & Development Tax Credit Extension
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Dana |
O'Brien |
|
|
|
Charles |
Crain |
|
|
|
Rina |
Singh |
|
|
|
Charles |
Fritts |
|
|
|
Sarah |
Thornton Caswell |
|
|
|
Kelly |
Cappio |
|
|
|
Phyllis |
Arthur |
|
|
|
Alan |
Eisenberg |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
World Trade Organization Special 301 Submissions
India Issues
Export Registrations for Products with Expired Patents
International Trade Commission Reform
Rep. Devin Nunes Discussion Draft
Foreign Agricultural Biotechnology Laws and Regulations
Low-Level Presence Foreign Government Policies
EU Biotechnology Bilateral Discussions
China Biotechnology Regulations
European Union Low Level Presence Policy
International Biotechnology Agreement
Asynchrony of International Approvals
Genetic Resource Patent Disclosure Requirement
World Intellectual Property Organization
TransPacific Partnership
Data and Intellectual Property Protection for Pharmaceuticals
Sanitary and Phytosanitary Issues
Regulatory Transparency
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), Agriculture - Dept of (USDA), State - Dept of (DOS), Patent & Trademark Office (PTO), Commerce - Dept of (DOC), Food & Drug Administration (FDA), White House Office,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Anna |
Weinstein |
|
|
|
David |
Edwards |
|
|
|
Dana |
O'Brien |
|
|
|
Lila |
Feisee |
|
|
|
Tom |
DiLenge |
|
|
|
Jeanne |
Haggerty |
|
|
|
Roy |
Zwahlen |
|
|
|
Matthew |
O'Mara |
|
|
|
Cathleen |
Enright |
|
|
|
Brent |
Del Monte |
|
|
|
Joseph |
Damond |
|
|
|
Charles |
Fritts |
|
|
|
Hans |
Sauer |
|
|
|
Dana |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
5 |
|
||||||
| 2 |
|
6 |
|
||||||
| 3 |
|
7 |
|
||||||
| 4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: BIO maintains a list of all of its members on its website at http://bio.org/membership/index.asp
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 3 | 5 |
| 2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 5 | 9 |
| 2 | 6 | 10 |
| 3 | 7 | 11 |
| 4 | 8 | 12 |